ALI DENKTAS to Risk Factors
This is a "connection" page, showing publications ALI DENKTAS has written about Risk Factors.
Connection Strength
0.254
-
Reduced-dose fibrinolytic acceleration of ST-segment elevation myocardial infarction treatment coupled with urgent percutaneous coronary intervention compared to primary percutaneous coronary intervention alone results of the AMICO (Alliance for Myocardial Infarction Care Optimization) Registry. JACC Cardiovasc Interv. 2008 Oct; 1(5):504-10.
Score: 0.028
-
Management of Acute Coronary Syndrome in Patients With Transcatheter Aortic Valve Replacement: A Review. Catheter Cardiovasc Interv. 2025 03; 105(4):959-969.
Score: 0.022
-
Readmission in patients undergoing percutaneous patent foramen ovale closure in the United States. Int J Cardiol. 2023 Jan 01; 370:143-148.
Score: 0.019
-
Decongestion Models and Metrics in Acute Heart Failure: ESCAPE Data in the Age of the Implantable Cardiac Pressure Monitor. Tex Heart Inst J. 2022 07 01; 49(4).
Score: 0.018
-
Impact of Hospital Procedural Volume on?Outcomes After Endovascular Revascularization for Critical Limb?Ischemia. JACC Cardiovasc Interv. 2021 09 13; 14(17):1926-1936.
Score: 0.017
-
Long-Term Outcomes of Veteran Patients After Transcatheter Aortic Valve Replacement. J Invasive Cardiol. 2021 09; 33(9):E730-E737.
Score: 0.017
-
Left Ventricle Mass Regression After Surgical or Transcatheter Aortic Valve Replacement in Veterans. Ann Thorac Surg. 2022 07; 114(1):77-83.
Score: 0.017
-
Mortality differences among patients with in-hospital ST-elevation myocardial infarction. Clin Cardiol. 2020 Dec; 43(12):1555-1561.
Score: 0.016
-
Coronavirus disease-19 and cardiovascular disease: A risk factor or a risk marker? Rev Med Virol. 2021 05; 31(3):e2172.
Score: 0.016
-
Network Analysis of Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement for Stenotic Bicuspid Aortic Valves According to Valve Type. Cardiovasc Revasc Med. 2020 09; 21(9):1076-1085.
Score: 0.015
-
Temporal trends, outcomes, and predictors of mortality after pericardiocentesis in the United States. Catheter Cardiovasc Interv. 2020 02 15; 95(3):375-386.
Score: 0.015
-
Outcomes of Veterans Undergoing TAVR Within Veterans Affairs Medical Centers: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. JACC Cardiovasc Interv. 2019 11 11; 12(21):2186-2194.
Score: 0.015
-
Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Peripheral Arterial and Ischemic Cerebrovascular Disease Compared to Veterans With Coronary Heart Disease. Am J Cardiol. 2016 Oct 15; 118(8):1144-1149.
Score: 0.012
-
Comparison of the use of hemodynamic support in patients =80 years versus patients <80 years during high-risk percutaneous coronary interventions (from the Multicenter PROTECT II Randomized Study). Am J Cardiol. 2014 Sep 01; 114(5):657-64.
Score: 0.010
-
Prognostic value of circulating pregnancy-associated plasma protein levels in patients with chronic stable angina. Eur Heart J. 2006 Jul; 27(14):1678-84.
Score: 0.006
-
Long-term prognostic value of coronary calcification detected by electron-beam computed tomography in patients undergoing coronary angiography. Circulation. 2001 Jul 24; 104(4):412-7.
Score: 0.004
-
Independent and incremental value of coronary artery calcium for predicting the extent of angiographic coronary artery disease: comparison with cardiac risk factors and radionuclide perfusion imaging. J Am Coll Cardiol. 1999 Sep; 34(3):777-86.
Score: 0.004